{
  "ptid_time": "116_S_4167_2013-08-22",
  "img_path": "/data/qiuhui/data/adni/images/116_S_4167/2013-08-22/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 44,593 mm³, 58.9% above the reference mean. With a Z-score of 1.35 (91.1th percentile), this represents mild enlargement; hippocampal volume measures 5,422 mm³, 23.8% below the reference mean. With a Z-score of -2.18 (1.5th percentile), this represents significant atrophy; whole brain volume measures 973,789 mm³, 0.1% below the reference mean. With a Z-score of -0.01 (49.6th percentile), this represents normal volume ; entorhinal cortex volume measures 2,599 mm³, 29.2% below the reference mean. With a Z-score of -1.79 (3.6th percentile), this represents moderate atrophy; fusiform gyrus volume measures 17,437 mm³, 2.5% above the reference mean. With a Z-score of 0.23 (59.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,570 mm³, 8.3% below the reference mean. With a Z-score of -0.72 (23.4th percentile), this represents normal volume . ",
  "text_data": "Age is 71.5 years. Gender is Female. Education: 16 years. MMSE: 21.0. MoCA: 14.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.37 SUVR (significant elevated); Amyloid beta: 519.30 pg/mL (mild reduced); Total tau: 281.70 pg/mL (normal ); Phosphorylated tau: 27.42 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal and entorhinal cortex atrophy, which are hallmark features of Alzheimer's disease (AD). The elevated AV45 (amyloid PET) and mildly reduced Aβ (CSF) further support amyloid pathology, while the cognitive scores (MMSE 21, MoCA 14) indicate moderate impairment.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **High**",
  "timestamp": "2025-07-26T12:08:14.682647"
}